According to Finance, ARK Invest has initiated a notable shift in its investment strategy by rotating out of two popular high-growth stocks that recently experienced sharp rallies. The firm moved to take profits on Robinhood (HOOD) and Roku (ROKU), converting these positions into liquid capital to fund new entries in the healthcare and cryptocurrency spaces.
Profit-taking on mature growth catalysts
The divestment from Robinhood was one of ARK's largest trims for the day. The firm sold 275,572 shares through its Innovation ETF, totaling approximately $26.65 million. This action followed a positive sentiment shift triggered by CEO Vlad Tenev’s announcement to cut roughly 10% of the company's full-time workforce. While the cost-cutting measures improved investor outlook on margins and led to higher price targets from analysts, Wood utilized the resulting momentum to lock in gains.
Similarly, ARK liquidated its position in Roku after a major acquisition announcement. The firm sold 239,267 shares across multiple ETFs, worth about $33.01 million, following news that Fox agreed to purchase Roku in a $22 billion deal valued at $160 per share. Because the takeover provided a defined price for shareholders, it effectively capped the remaining upside potential, prompting Wood to exit the position.
Strategic pivots into healthcare and fintech
The capital harvested from these sales was immediately redeployed into several high-demand names. ARK Invest notably increased its stake in Eli Lilly, purchasing 41,138 shares through its Genomic Revolution ETF for roughly $46.18 million. This move follows the drugmaker's acquisition of 4E Therapeutics, expanding its reach beyond weight-loss medications into neuroscience and chronic pain treatments.
Other significant additions to the portfolio include:
- Coinbase: ARK purchased 111,799 shares for approximately $18.92 million as the platform expands into tokenized stocks and AI-driven tools.
- Block: The firm added $17.68 million in new positions to the payments giant.
- SpaceX: Wood built a major post-IPO position of nearly 3.3 million shares, valued at roughly $531 million on its first trading day.
Portfolio composition and outlook
Despite these rotations, the ARK Innovation ETF maintains a heavy concentration in disruptive growth names. Tesla remains the largest holding at 9.50%, followed by Robinhood at 4.93% and CRISPR Therapeutics at 4.87%. The current strategy suggests that while Wood is willing to exit stocks with limited remaining upside, she remains committed to high-risk, high-reward assets that offer significant platform-like science or market expansion.